CONCLUSIONS
CGM feedback have the potential to offer pregnant patients a way to
monitor their glucose levels during pregnancy, allowing improvement in
glucose control through behavioural change and reducing the risk of
developing GDM. Future trials of a larger sample size coupled with
better education and guidance by health care professionals regarding the
use and interpretation of the glucose sensor readings are required for
better clinical outcomes.